About PCI Pharma Services
PCI Pharma Services is a Healthcare company based in Philadelphia (United States) founded in 1997. Clinical and commercial supply chain and packaging solutions are provided. It operates on a Professional Services model. PCI Pharma Services has completed 10 acquisitions, including Ajinomoto Bio-Pharma, AndersonBrecon and Bellwyck. Its chief executive, as recorded, is Salim Haffar. Its website pci.com draws about 53 thousand monthly visits. PCI Pharma Services offers products and services including Development & Manufacturing, Clinical Trial Services, Advanced Drug Delivery, Commercial Packaging, and Speed Solutions. Its focus areas include Pharmaceuticals and Contract Development and Manufacturing. Its competitors include Asymchem, Continuus Pharma and Pharmaceutics International; 1 of its 3 listed competitors has raised funding.
Company details
PCI Pharma Services is involved in offering comprehensive pharmaceutical services ranging from early-stage drug development to commercialization. The company operates in the healthcare sector, focusing on contract development and manufacturing. Solutions provided include clinical trial services, advanced drug delivery, commercial packaging, and speed solutions for accelerated development. With over five decades of experience, more than 90 successful product launches annually, and a global presence through 30 GMP facilities, the organization supports clients in delivering life-changing therapies.
- InvestorsMubadala
& 5 more
- Investments & AcquisitionsAjinomoto Bio-Pharma
& 9 more
Products & Services of PCI Pharma Services
PCI Pharma Services offers a comprehensive portfolio of products and services, including Development & Manufacturing, Clinical Trial Services, Advanced Drug Delivery, Commercial Packaging, and Speed Solutions.
Services for drug development and manufacturing are provided.
Support for clinical trials is offered to clients.
Innovative drug delivery solutions are developed for clients.
Packaging solutions for commercial drugs are provided here.
Accelerated drug development services are offered to clients.
Apps and channels of PCI Pharma Services
its YouTube channel PCI Pharma Services has 247 subscribers and 30 videos.
Videos from PCI Pharma Services
The most watched videos on PCI Pharma Services's YouTube channel, PCI Pharma Services (247 subscribers). Click a video to play it here.
More on PCI Pharma Services.
Funding Insights of PCI Pharma Services
- Total Rounds 5
- Investors Count 6
All 5 funding rounds of PCI Pharma Services with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2025 | Private Equity Round | – | Bain Capital Private Equity, Kohlberg & Company | ||
| Dec 2021 | Seed | – | – | ||
| Jun 2016 | Private Equity Round | – | Thomas H Lee Partners | – | |
| May 2013 | $205M | Debt – Conventional | – | – | – |
| Jun 2012 | Private Equity Round | – | Frazier Healthcare Partners | – |
6 investors in total: 6 institutional.
Investors in PCI Pharma Services
PCI Pharma Services has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Mubadala, Bain Capital Private Equity and Frazier Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are directed toward traditional industries. | 1974 | thl.com | Boston, United States | |
Healthcare sector private equity investments are managed by the firm. | 1991 | frazierhealthcare.com | Seattle, United States | |
Private investment firm managing assets and expanding into equity, credit, and real estate services. | 1984 | baincapitalprivateequity.com | London, United Kingdom | |
Private equity investment firm focused on buyouts | kohlberg.com | Mount Kisco, United States | ||
Sovereign wealth fund of United Arab Emirates | 2002 | mubadala.com | Abu Dhabi, United Arab Emirates | |
| aimco.ca |
Investor details for PCI Pharma Services
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PCI Pharma Services
554 people are tracked at PCI Pharma Services (131 in leadership, 423 in team).
| Name | Role | Group |
|---|---|---|
Salim Haffar | CEO | Leadership |
Kerry Kingdom | Head Of Process Optimisation And Validation | Leadership |
Thomas Cliggett | Director Quality Operations | Leadership |
Bridget McGreehan | Executive Director, Human Resources & Social Sustainability | Leadership |
Kelly Brennan Aphr | Executive Director Human Resources & Social Sustainability | Leadership |
Samantha Mendenhall | Executive Director, Human Resources | Leadership |
Bryan K. Bradley | Senior Director Finance | Leadership |
Marsha Etzkorn | Director Of Technical Accounting | Leadership |
Antonio Sanz | Vice President Global Finance | Leadership |
Balbir Chana Cpa | Director Of Finance | Leadership |
Paul Smyth | Finance Director | Leadership |
Kelvin Jones | Financial Director | Leadership |
Lynn Pulfer | Director, Global Clinical Processes | Leadership |
Victoria Wichard Msc Fifst | Head Of Operations | Leadership |
Allison Crull | Sr. Director, IT PMO | Leadership |
Greig Ross | Senior Director, Business Development | Leadership |
Pat Kelly | Senior Director Of Operations | Leadership |
Rob Jones | Executive Director Business Development International | Leadership |
Phil Digiacomo | Sr VP Of Sales And Marketing | Leadership |
Christa Denning | Executive Director/human Resources Leader - Workday, Talent Acquisition, Talent Development | Leadership |
534 more people are available in the full profile.
Complete people profiles for PCI Pharma Services
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PCI Pharma Services
PCI Pharma Services has strategically engaged in corporate development activities, having acquired 10 companies. Notable acquisitions include Ajinomoto Bio-Pharma, AndersonBrecon and Bellwyck.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Small and large molecules are developed and manufactured. | ajibio-pharma.com | San Diego, United States | 2018 | Apr 2025 | •••• | |
CDMO providing lyophilization services for small molecules and biologics | lyophilization.com | Manchester, United States | 1997 | Oct 2021 | •••• | |
Provider of packaging & pharma and healthcare solutions | bellwyck.com | Toronto, Canada | 2012 | Feb 2020 | •••• | |
Bellwyckpharmaservices is identified as a pharmaceutical services provider. | bellwyckpharmaservices.com | 0 | Feb 2020 | •••• | ||
Clinical trial packaging, labeling, and cold chain services are provided. | sherpaclinical.com | San Diego, United States | 2010 | Sep 2018 | •••• | |
Provider of packaging, labeling, clinical trial, storage & distribution services | pharmpackpro.com | Thebarton, Australia | 2008 | Feb 2018 | •••• | |
Contract packaging services for tablets are provided in cleanroom environments. | millmounthealthcare.com | Drogheda, Ireland | 1996 | Oct 2017 | •••• | |
Provider of drug development, clinical trials supply, packaging, and storage services | biotec-uk.com | Bridgend, United Kingdom | 1997 | Sep 2014 | •••• | |
CDMO/CMO for fully integrated pharma development and manufacturing services | pennpharm.com | Tredegar, United Kingdom | 1997 | Jul 2014 | $215.54M | |
Provides contract pharmaceutical packaging services for reliable and compliant solutions. | andersonbrecon.com | Illinois, United States | 1967 | Apr 2013 | $308M |
Complete acquisition details for PCI Pharma Services
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of PCI Pharma Services
13 dated milestones of PCI Pharma Services across 28 years, from founding to its latest funding, stage changes and deals.
- Founded PCI Pharma Services is founded.
- Funding First funding round.
- Acquisition Acquires AndersonBrecon.
- Acquisition Acquires Penn Pharma.
- Acquisition Acquires Biotec Services International.
- Acquisition Acquires Millmount Healthcare.
- Acquisition Acquires Pharmaceutical Packaging Professionals.
- Acquisition Acquires Sherpa Clinical.
- Acquisition Acquires Bellwyck.
- Acquisition Acquires Bellwyckpharmaservices.
- Acquisition Acquires Lyophilization Services of New England.
- Acquisition Acquires Ajinomoto Bio-Pharma.
- Funding Latest funding round, Private Equity Round,.
Competitors of PCI Pharma Services
PCI Pharma Services has 3 listed competitors in our database, 1 of them funded. They include Asymchem, Continuus Pharma and Pharmaceutics International.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| asymchem.com | 1995 | Morrisville, United States | 48 | APIs and peptides are developed and manufactured by Asymchem. | ||
| continuuspharma.com | 2012 | Woburn, United States | $7.73M | 47 | MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | |
| pharm-int.com | 1994 | Hunt Valley, United States | 248 | Pharmaceutical dosage forms are manufactured by this CDMO. |
Detailed competitors of PCI Pharma Services
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PCI Pharma Services
The website of PCI Pharma Services (pci.com) receives about 52.7K visits a month and ranks #741,848 among all websites worldwide, #3,939 in Telecommunications.
- Monthly visits52.7K
▲ 37.4% vs previous month
- Unique visitors17.5K
per month
- Global rank#741,848
among all websites
- Category rank#3,939
Computers Electronics and Technology · Telecommunications
- Bounce rate40%
- Pages per visit2.4
- Average visit52 sec
- DevicesDesktop 40% · Mobile 60%
Websites whose visitors overlap most with PCI Pharma Services. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bics.com | 100% | 56.1K | #596,291 | View details | |
| telmarnt.com | 94% | View details | |||
jourdantechnologies.com | jourdantechnologies.com | 94% | – | ||
ips.si | ips.si | 94% | – | ||
| genband.com | 94% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for PCI Pharma Services
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as PCI Pharma Services (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pci Pharma Services
Complete news archive for PCI Pharma Services
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PCI Pharma Services
PCI Pharma Services was founded in 1997 and raised its 1st funding round 15 years after it was founded.
PCI Pharma Services is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Salim Haffar is the CEO of PCI Pharma Services, as recorded in our data.
PCI Pharma Services is involved in offering comprehensive pharmaceutical services ranging from early-stage drug development to commercialization. The company operates in the healthcare sector, focusing on contract development and manufacturing. Solutions provided include clinical trial services, advanced drug delivery, commercial packaging, and speed solutions for accelerated development. With over five decades of experience, more than 90 successful product launches annually, and a global presence through 30 GMP facilities, the organization supports clients in delivering life-changing therapies.
PCI Pharma Services's top competitors include Pharmaceutics International, Asymchem and Continuus Pharma.
PCI Pharma Services offers Development & Manufacturing, Clinical Trial Services, Advanced Drug Delivery, Commercial Packaging, and Speed Solutions.
PCI Pharma Services has made 10 acquisitions, including Ajinomoto Bio-Pharma, AndersonBrecon, and Bellwyck.
PCI Pharma Services has 6 investors. Key investors include Mubadala, Bain Capital Private Equity, Frazier Healthcare Partners, Thomas H Lee Partners, and Kohlberg & Company.